Remimazolam for sedation during gynecologic surgery
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests a sedative called remimazolam to see how well it works and how safe it is for women having gynecologic surgery. It aims to find the best way to keep patients comfortable and stable during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old
- Your body mass index (BMI) is between 18 and 30
- You are in good health or have mild health problems (classified as ASA I or II)
- You are scheduled for a gynecologic surgery such as hysterectomy, removal of ovaries or fallopian tubes, or fibroid removal
- You are not allergic to sedatives like benzodiazepines (e.g., Valium)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a sedative called remimazolam helps you sleep better after surgery compared to other options. You may benefit if you are having a short procedure and want to improve your post-surgery rest.
This trial tests a newer anesthetic drug, remimazolam, during heart surgery that uses a heart-lung machine. It aims to see if it is safe and works well for patients having this type of surgery.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This trial tests if remimazolam, a sedative, can reduce low oxygen levels during a procedure to collect eggs from the ovaries. It may be a safer option for people having this fertility treatment.
This trial tests a sedative called remimazolam for people with serious health conditions who need an ERCP, a procedure to examine the bile ducts. It aims to find a safer sedation option for those at higher risk.
Hear when a new Gynecological Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.